Ultragenyx to Present at the Canaccord Genuity 32nd Annual Growth Conference on August 16, 2012

NOVATO, Calif., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc., a biotechnology company, today announced that Emil D. Kakkis, MD, PhD, President and CEO, will be presenting at the Canaccord Genuity 32nd Annual Growth Conference in Boston, Massachusetts on Thursday, August 16, 2012 at 9:30am Eastern Time. The conference is being held at the InterContinental Boston Hotel located at 510 Atlantic Avenue Boston, MA 02210.